HLN
Price
$10.87
Change
-$0.14 (-1.27%)
Updated
Jun 13 closing price
Capitalization
38.4B
46 days until earnings call
UPC
Price
$3.98
Change
+$0.09 (+2.31%)
Updated
Jun 13 closing price
Capitalization
7.98M
Interact to see
Advertisement

HLN vs UPC

Header iconHLN vs UPC Comparison
Open Charts HLN vs UPCBanner chart's image
Haleon
Price$10.87
Change-$0.14 (-1.27%)
Volume$10.81M
Capitalization38.4B
Universe Pharmaceuticals
Price$3.98
Change+$0.09 (+2.31%)
Volume$44.84K
Capitalization7.98M
HLN vs UPC Comparison Chart
Loading...
HLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UPC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HLN vs. UPC commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HLN is a Hold and UPC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 15, 2025
Stock price -- (HLN: $10.87 vs. UPC: $3.98)
Brand notoriety: HLN and UPC are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: HLN: 65% vs. UPC: 11%
Market capitalization -- HLN: $38.4B vs. UPC: $7.98M
HLN [@Pharmaceuticals: Other] is valued at $38.4B. UPC’s [@Pharmaceuticals: Other] market capitalization is $7.98M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HLN’s FA Score shows that 0 FA rating(s) are green whileUPC’s FA Score has 1 green FA rating(s).

  • HLN’s FA Score: 0 green, 5 red.
  • UPC’s FA Score: 1 green, 4 red.
According to our system of comparison, HLN is a better buy in the long-term than UPC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HLN’s TA Score shows that 3 TA indicator(s) are bullish while UPC’s TA Score has 2 bullish TA indicator(s).

  • HLN’s TA Score: 3 bullish, 4 bearish.
  • UPC’s TA Score: 2 bullish, 7 bearish.
According to our system of comparison, HLN is a better buy in the short-term than UPC.

Price Growth

HLN (@Pharmaceuticals: Other) experienced а -1.81% price change this week, while UPC (@Pharmaceuticals: Other) price change was -7.23% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.40%. For the same industry, the average monthly price growth was +14.50%, and the average quarterly price growth was +66.97%.

Reported Earning Dates

HLN is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-0.40% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HLN($38.4B) has a higher market cap than UPC($7.99M). HLN has higher P/E ratio than UPC: HLN (29.23) vs UPC (3.00). HLN YTD gains are higher at: 15.245 vs. UPC (-83.689). HLN has higher annual earnings (EBITDA): 2.35B vs. UPC (-7.29M). HLN has more cash in the bank: 994M vs. UPC (5.71M). UPC has less debt than HLN: UPC (3.94M) vs HLN (9.46B). HLN has higher revenues than UPC: HLN (11.3B) vs UPC (40.1M).
HLNUPCHLN / UPC
Capitalization38.4B7.99M480,902%
EBITDA2.35B-7.29M-32,259%
Gain YTD15.245-83.689-18%
P/E Ratio29.233.00974%
Revenue11.3B40.1M28,180%
Total Cash994M5.71M17,405%
Total Debt9.46B3.94M240,244%
TECHNICAL ANALYSIS
Technical Analysis
HLNUPC
RSI
ODDS (%)
Bearish Trend 3 days ago
42%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
69%
Bullish Trend 3 days ago
88%
Momentum
ODDS (%)
Bearish Trend 3 days ago
54%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
59%
Bearish Trend 3 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
46%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
52%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
58%
Bullish Trend 28 days ago
84%
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
48%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
51%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
HLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UPC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IONS35.59-0.03
-0.08%
Ionis Pharmaceuticals
CELU1.75-0.01
-0.57%
Celularity
DMLP28.10-0.21
-0.74%
Dorchester Minerals LP
MAR254.99-8.24
-3.13%
Marriott International
MRVI2.13-0.13
-5.75%
Maravai LifeSciences Holdings

UPC and

Correlation & Price change

A.I.dvisor tells us that UPC and CPHRF have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that UPC and CPHRF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UPC
1D Price
Change %
UPC100%
+2.31%
CPHRF - UPC
26%
Poorly correlated
-2.21%
RAFA - UPC
22%
Poorly correlated
-3.62%
HYEX - UPC
8%
Poorly correlated
-12.44%
TKNO - UPC
6%
Poorly correlated
-5.68%
HLN - UPC
5%
Poorly correlated
-1.27%
More